PaulYoung
I think you ahd a pretty good go at projecting the income stream from Cvac and using a conservative PE multiple to extrapolate a downstream share price value.
The one factor i would take issue with is your assumption of a 50% gross profit margin. The largest proportion would be manufacturing cost of goods (vaccine). Some time ago at a Sth Cross Equities seminar I asked MR what the production cost of Cvac would be. He was very careful in answering the question as it could be construed as potentially market sensitive and proprietary, but the gist was it's relatively inexpensive to manufacture on a commercial scale, once the correct facilities are up and running.
Like most blockbuster pharmaceuticles, all the cost is in the development phase. The first pill costs $200 million to produce, the next one costs 5 cents. Not a perfect analogy I know, but close enough.
Cheers
K
- Forums
- ASX - By Stock
- IMM
- buy side is building
buy side is building, page-45
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.5¢ |
Change
-0.010(2.47%) |
Mkt cap ! $570.1M |
Open | High | Low | Value | Volume |
39.5¢ | 40.8¢ | 39.0¢ | $1.291M | 3.270M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 160217 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 119125 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 160217 | 0.395 |
2 | 3857 | 0.390 |
3 | 73188 | 0.385 |
6 | 81173 | 0.380 |
2 | 38500 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 119125 | 4 |
0.410 | 237258 | 6 |
0.415 | 86091 | 5 |
0.420 | 494057 | 7 |
0.425 | 69000 | 3 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |